These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study. Pilowsky LS; Busatto GF; Taylor M; Costa DC; Sharma T; Sigmundsson T; Ell PJ; Nohria V; Kerwin RW Psychopharmacology (Berl); 1996 Mar; 124(1-2):148-53. PubMed ID: 8935810 [TBL] [Abstract][Full Text] [Related]
17. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT. Schelosky L; Hierholzer J; Wissel J; Cordes M; Poewe W Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354 [TBL] [Abstract][Full Text] [Related]
18. No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys. Vermeulen RJ; Drukarch B; Verhoeff NP; Goosen C; Sahadat MC; Wolters EC; van Royen EA; Stoof JC Synapse; 1994 Jun; 17(2):115-24. PubMed ID: 7916490 [TBL] [Abstract][Full Text] [Related]